| Thalidomide in multiple myeloma: lack of response of soft‐tissue plasmacytomas J Bladé, M Perales, L Rosiñol, M Tuset, S Montoto, J Esteve, F Cobo, ... British journal of haematology 113 (2), 422-424, 2001 | 125 | 2001 |
| Predictive value of Follicular Lymphoma International Prognostic Index (FLIPI) in patients with follicular lymphoma at first progression S Montoto, A Lopez-Guillermo, A Altes, G Perea, A Ferrer, M Camós, ... Annals of oncology 15 (10), 1484-1489, 2004 | 95 | 2004 |
| Conventional versus reduced-intensity conditioning regimen for allogeneic stem cell transplantation in patients with hematological malignancies. D Valcárcel, R Martino, A Sureda, C Canals, A Altés, J Briones, SM Angel, ... European Journal of Haematology 74 (2), 144-15, 2005 | 84 | 2005 |
| Can sTREM-1 predict septic shock & death in late-onset neonatal sepsis? A pilot study V Arízaga-Ballesteros, MR Alcorta-García, LC Lázaro-Martínez, ... International Journal of Infectious Diseases 30, 27-32, 2015 | 50 | 2015 |
| Acute myeloid leukaemia: optimal management and recent developments L Villela, J Bolaños-Meade Drugs 71, 1537-1550, 2011 | 42 | 2011 |
| Low transplant related mortality in older patients with hematologic malignancies undergoing autologous stem cell transplantation L Villela, A Sureda, C Canals, MA Sanz, R Martino, D Valcárcel, A Altés, ... haematologica 88 (3), 300-305, 2003 | 32 | 2003 |
| Prognostic features and outcome in patients with diffuse large B‐cell lymphoma who do not achieve a complete response to first‐line regimens L Villela, A López‐Guillermo, S Montoto, S Rives, F Bosch, M Perales, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2001 | 26 | 2001 |
| Rapid complete response using intrathecal rituximab in a patient with leptomeningeal lymphomatosis due to mantle cell lymphoma L Villela, M García, R Caballero, JR Borbolla-Escoboza, ... Anti-cancer drugs 19 (9), 917-920, 2008 | 25 | 2008 |
| Aminoglycoside-associated severe renal failure in patients with multiple myeloma treated with thalidomide C Montagut, F Bosch, L Villela, L Rosiñol, J Bladé Leukemia & lymphoma 45 (8), 1711-1712, 2004 | 20 | 2004 |
| Efficacy and safety of canakinumab in the treatment of adult-onset Still's disease: A systematic review JM Cota-Arce, J Cota, MA De León-Nava, A Hernández-Cáceres, ... Seminars in Arthritis and Rheumatism 51 (6), 1282-1290, 2021 | 17 | 2021 |
| Real-world data on adult T-cell leukemia/lymphoma in Latin America: a study from the Grupo de Estudio Latinoamericano de Linfoproliferativos L Malpica, DJ Enriquez, DA Castro, C Peña, H Idrobo, L Fiad, M Prates, ... JCO global oncology 7, 1151-1166, 2021 | 17 | 2021 |
| Analysis of IgG, IgA and IgM antibodies against SARS‐CoV‐2 spike protein S1 in convalescent and vaccinated patients with the pfizer‐BioNTech and CanSinoBio vaccines EA Melgoza‐González, D Hinojosa‐Trujillo, M Reséndiz‐Sandoval, ... Transboundary and Emerging Diseases 69 (4), e734-e745, 2022 | 15 | 2022 |
| Cytotoxic activity of a black bean (Phaseolus vulgaris L.) extract and its flavonoid fraction in both in vitro and in vivo models of lymphoma U Aregueta-Robles, OR Fajardo-Ramírez, L Villela, JA Gutiérrez-Uribe, ... Revista de investigación clínica 70 (1), 32-39, 2018 | 14 | 2018 |
| Osteopetrosis, calcificación más allá del sistema óseo. Reporte de un caso P Mejía Osuna, J Santos-Guzmán, L Villela, EJ Cedillo-Alemán, A García Boletín médico del Hospital Infantil de México 69 (2), 116-120, 2012 | 13 | 2012 |
| Nodular regenerative hyperplasia associated to aplastic anemia: a case report and literature review MS González-Huezo, LM Villela, M del Carmen Zepeda-Florencio, ... Annals of Hepatology 5 (3), 166-169, 2006 | 13 | 2006 |
| Integración y comercio en América: impacto fiscal de la liberalización comercial en América AD Barreix, LA Villela, J Roca Inter-American Development Bank, 2004 | 11 | 2004 |
| Discriminant analysis and machine learning approach for evaluating and improving the performance of immunohistochemical algorithms for COO classification of DLBCL. Y Perfecto-Avalos, A Garcia-Gonzalez, A Hernandez-Reynoso, ... Journal Translational Medicine 17 (1), 1-12, 2019 | 9 | 2019 |
| Advantages of drug selective distribution in cancer treatment: Brentuximab Vedotin L Mario Villela-Martinez, A Karen Velez-Ayala, ... International Journal of Pharmacology 13 (7), 785-807, 2017 | 9 | 2017 |
| A PER3 polymorphism is associated with better overall survival in diffuse large B-cell lymphoma in Mexican population MA Gutiérrez-Monreal, L Villela, S Baltazar, Y Perfecto-Avalos, ... Cancer Biomarkers 15 (5), 699-705, 2015 | 9 | 2015 |
| Guías nacionales de diagnóstico y tratamiento de linfoma no Hodgkin M Candelaria, E Cervera-Ceballos, A Meneses-García, A Avilés-Salas, ... Revista de Investigación Clínica 65 (suppl 2), S5-S26, 2013 | 9 | 2013 |
